The largest community of pharma leaders

Novaremed Announces Management Changes

BASEL, Switzerland–(BUSINESS WIRE)–Novaremed AG (Novaremed), a clinical-stage Swiss biopharmaceutical company, announced today that by mutual agreement with the Board of Directors, Dr. Nicholas Draeger has decided to step down as CEO and member of the Board of Directors and will serve as a senior advisor to Novaremed in order to ensure a smooth leadership transition. The search for a full-time successor to Dr. Draeger has been initiated. Mr. Subhasis Roy, COO, and Dr. Sara Mangialaio, CMO and….

Recent Articles